EarningsCanvas
Loading your research…
Opening the latest published company and exchange records.
EarningsCanvas
Opening the latest published company and exchange records.
NSE · NSE SME · BSE
Results, orders and company updates, with a trail back to the filing. Check the feed status below for freshness.
Exchange intelligence
An exchange could not be refreshed. These are last known disclosures. Check the official exchange for newer announcements.
Mankind Pharma Limited has informed the Exchange regarding allotment of 38442 securities pursuant to ESOP/ESPS at its meeting held on November 19, 2026
Intimation of Change in Corporate Identification Number (CIN) pursuant to alteration of the object clause of the Memorandum of Association.
D-Link (India) Limited has informed the Exchange regarding Proceedings of undefined held on November 13, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
Mankind Pharma Limited has informed the Exchange about General Updates
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, please find enclosed herewith transcript of Q2FY27 Earnings Call held on Friday, November 6, 2026 at 11:30 AM
D-Link (India) Limited has informed the Exchange about Intimation of Change in Address of the Registrar and Transfer Agent of the Company.
Pursuant to Regulation 47 read with Regulation 46(2)(q) of the SEBI (LODR) Regulations, 2015, please find enclosed herewith the newspaper advertisement for the unaudited financial results of the Company for the quarter and half year ended September 30, 2026 in the following newspaper: 1) Financial Express (English) 2) Navshakti (Marathi).
The audio recording of the Q2 and H1FY27 earnings call held on Friday, November 6, 2026 at 11:30 AM has been uploaded on website of the Company.
JNK India Limited has informed the Exchange about Resignation of Director/KMP/SMP
Mankind Pharma Limited has informed the Exchange about Schedule of meet
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we are enclosing herewith the Q2 and H1FY27 press release dated November 6, 2026.
JNK India Limited has informed the Exchange about Investor Presentation
JNK India Limited has informed the Exchange regarding Appointment of Mr. Praveen Sood as Chief Financial Officer of the company w.e.f. November 12, 2026.
JNK India Limited has informed the Exchange regarding Cessation of Mr. Anand Agarwal as Interim Chief Financial Officer of the company w.e.f. November 05, 2026.
JNK India Limited has informed the Exchange regarding Resignation of Mr. Anand Agarwal as Interim Chief Financial Officer of the company w.e.f. November 05, 2026.
Unaudited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30, 2026 alongwith limited review report.
Outcome of the Board meeting for the unaudited (standalone and consolidated) Financial Results of the Company for the quarter and half year ended September 30, 2026 along with limited review report.
Mankind Pharma Limited has informed the Exchange about General Updates
JNK India Limited has informed the Exchange about Bagging/Receiving of orders/contracts
Mankind Pharma Limited has informed the Exchange about Schedule of meet
Pursuant to regulation 30 of SEBI (LODR) Regulations, 2015 we are enclosing herewith the schedule of Analyst/Institutional Investors meeting with the Company.
D-Link (India) Limited has informed the Exchange about Copy of Newspaper Publication
D-Link (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Mankind Pharma Limited has informed the Exchange about Transcript
Mankind Pharma Limited has informed the Exchange about Credit Rating
Bank Of India has informed the Exchange regarding 'change in MCLR w.e.f.01.11.2026'.
NK Industries Limited has submitted to the Exchange, the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.
Mankind Pharma Limited has informed the Exchange about Investor Presentation
Mankind Pharma Limited has informed the Exchange about Copy of Newspaper Publication
Mankind Pharma Limited has informed the Exchange about Link of Recording
Mankind Pharma Limited has informed the Exchange about Investor Presentation
Mankind Pharma Limited has informed the Exchange about Investor Presentation
Mankind Pharma Limited has informed the Exchange regarding a press release dated October 26, 2026, titled "Press Release on Financial Results for Q2 & H1 FY27".
Please find attached outcome of Board Meeting where Board has noted the merger of MCPPL & UAPL
Mankind Pharma Limited has informed the Exchange about Scheme of Arrangement
Mankind Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Bank Of India has informed the Exchange about Link of Recording and Outcome of Analyst/Investor meet